Boceprevir – Experimental Drug for Chronic Hepatitis C Infection
Key Data:
Drug (Brand/Generic)
Boceprevir
Company/Licensee
Schering-Plough
Therapy Class
HCV protease inhibitor
Product Description
Inhibits HCV viral replication
Current Indication
Chronic HCV infection
Market Sector
Anti-infectives
Development Status
Phase III
